Oncopeptides’ Pepaxto Withdrawal Speeds Through In 7 Months Under Expedited Procedures

 
• By Sue Sutter, Nancy Pham, and Kosh Naran
Foot race
Pepaxto marked the fastest accelerated approval withdrawal from CDER proposal to final agency order. • Source: Shutterstock

More from Post-Marketing Regulation & Studies

More from Product Reviews